Investor presentation Half Year Results 31 December 2021
Filed with ASX · · 19 pages · English
Disclaimer This presentation has been prepared by Nova Eye Medical Limited (ASX: EYE). While the information in this presentation has been prepared in good faith and with reasonable care, no representation or warranty, express or implied, is made as to the accuracy, adequacy or reliability of any statement, estimates, opinions or other information contained in the presentation. This presentation m
In the deck
Story so far
Earlier from Nova Eye Medical
- Half year results discussion
- Glaucoma Sales Update
- EYE AGM Presentation
- US Government Stimulus Loan Forgiven
- Aquisition of Glaucoma Patents
Later from Nova Eye Medical
- Nova Eye Medical Launches Next Generation Canaloplasty Device for Glaucoma, iTrack™ Advance
- 2RT Pivotal Study and Regulatory Pathway
- AlphaRet Investor Presentation
- iTrack Advance Commercial Roll-Out Commenced
- Appendix 4E and Annual Report FY22
Follow Nova Eye Medical into a list and get an email when it puts out news.
Follow Nova Eye Medical